Clinical Practice Guidelines for post‐ERCP pancreatitis 2023
Digestive Endoscopy · 2025-06 · 37 (6) · 573-587
DOI: 10.1111/den.15004 ↗Kurz gefasst
Leitlinie in der Zeitschrift Digestive Endoscopy, online erschienen am 25.03.2025. Verfasst von Shuntaro Mukai und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Cholangiopancreatography, Endoscopic Retrograde, Pancreatitis, Postoperative Complications. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 117 Literaturangaben. Gefördert von: Japan Pancreas Society.
Abstract (Originalsprache)
The Clinical Practice Guidelines for post‐ERCP pancreatitis (PEP) 2023 provide updated recommendations for the prevention, diagnosis, and management of PEP. Endoscopic retrograde cholangiopancreatography (ERCP), a valuable procedure for diagnosing and treating pancreatobiliary diseases, can result in PEP as the most common adverse event. Since the first guidelines were published in 2015, advances in techniques and new research findings have necessitated this revision. The guidelines developed using the GRADE methodology target adult patients undergoing ERCP. They offer a comprehensive framework for clinicians to minimize the risk of PEP. For high‐risk patients, endoscopic ultrasound before ERCP is recommended to avoid unnecessary procedures. The guidelines also discuss procedural and patient‐related risk factors for PEP, highlighting that operator experience does not significantly affect PEP rates if performed under the supervision of skilled endoscopists. The diagnostic criteria include monitoring serum pancreatic enzyme levels postprocedure, and early computed tomography is advised in suspected cases. For treatment, the guidelines recommend following acute pancreatitis protocols. Key preventive measures include the use of temporary pancreatic duct stents and rectal nonsteroidal anti‐inflammatory drugs, both of which are supported by strong evidence for reducing the incidence of PEP. Overall, these guidelines aim to enhance clinical outcomes by reducing PEP incidence and improving its management through evidence‐based practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
- Department of Surgery, Osaka Gyoumeikan Hospital, Osaka, Japan.
- Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
- Department of Gastroenterology, Dokkyo Medical University School of Medicine, Tochigi, Japan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
- Center for Gastroenterology, Teine Keijinkai Hospital, Hokkaido, Japan.
ORCID-Profile: Shuntaro Mukai, Takao Itoi, Atsushi Irisawa, Eisuke Iwasaki, Akio Katanuma, Katsuya Kitamura, Mamoru Takenaka, Morihisa Hirota, Shomei Ryozawa
Förderung
- Japan Pancreas Society
Zitieren
APA
Mukai, S., Takeyama, Y., Itoi, T., Ikeura, T., Irisawa, A., Iwasaki, E., Katanuma, A., Kitamura, K., Takenaka, M., Hirota, M., Mayumi, T., Morizane, T., Yasuda, I., Ryozawa, S., & Masamune, A. (2025). Clinical Practice Guidelines for post‐ERCP pancreatitis 2023. Digestive Endoscopy, 37(6), 573-587. https://doi.org/10.1111/den.15004
Vancouver
Mukai S, Takeyama Y, Itoi T, Ikeura T, Irisawa A, Iwasaki E, et al. Clinical Practice Guidelines for post‐ERCP pancreatitis 2023. Digestive Endoscopy. 2025;37(6):573-587. doi:10.1111/den.15004
BibTeX
@article{Mukai2025,
author = {Mukai, Shuntaro and Takeyama, Yoshifumi and Itoi, Takao and Ikeura, Tsukasa and Irisawa, Atsushi and Iwasaki, Eisuke and Katanuma, Akio and Kitamura, Katsuya and Takenaka, Mamoru and Hirota, Morihisa and Mayumi, Toshihiko and Morizane, Toshio and Yasuda, Ichiro and Ryozawa, Shomei and Masamune, Atsushi},
title = {Clinical Practice Guidelines for post‐ERCP pancreatitis 2023},
journal = {Digestive Endoscopy},
year = {2025},
volume = {37},
number = {6},
pages = {573--587},
doi = {10.1111/den.15004}
}
EUVIMED